Pneumonia (Lecture3)

You might also like

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 50

Pneumonia

Dr Ibrahim Bashayreh, RN, PhD.

28/10/2009

Pneumonia
Acute inflammation of lung (lower
respiratory tract) caused by
microorganism, comes with fever,
focal chest symptoms, shadowing
on CXR
Leading cause of death until 1936
Discovery of sulfa drugs and

penicillin

28/10/2009

Classification
Community Acquired Pneumonia
Occur within 48 hrs of admission or in

patients who havent been hospitalized in the


last 2 wks
Strep pneumonia, mycoplasma pneumonia,
influenza A, Haemophilus influenza, and
Legionella are more common pathogens
Patients with chronic diseases are more prone
to Klebsiella and other gram negative
organisms
Highest incidence in winter
Smoking important risk factor

28/10/2009

Types of Pneumonia
Hospital-acquired pneumonia (HAP) (Nasocomial Infection)
Develops 2

or more days after admission


Gram negative bacilli (Klebsiella, Pseudomonas, E coli,
Proteus) or Staphylococcus are more common pathogens
Aspiration around an ETT/reduced consciousness or
difficulty swallowing allows pathogens in the oropharynx to
colonize the lungs
Ventilator-associated pneumonia (VAP): in patients on
ventilators
Aspiation: follows aspiration of gastric contents
Immunosuppression: chemotherapy/bone marrow
transplant/HIV patients susceptible to fungi and viral
infections as well as other pathogen
Highest mortality rate of nosocomial infections
28/10/2009

Causes of HAP
Pseudomonas
Enterobacter
S. aureus
S. pneumoniae
Immunosuppressive therapy
General debility
Endotracheal intubation

28/10/2009

Aging, 65 years or older


Male
Children under 2
Having HIV or AIDS
Increased frequency of gram- negative bacilli
(leukemia, diabetes, alcoholism)
Smoking
Being around certain chemicals
Living in certain parts of the country
Being hospitalized in ICU & having ETT
Pollution
Malnutrition
28/10/2009

Acquisition of Organisms
Aspiration from nasopharynx,
oropharynx
Inhalation of microbes
Hematogenous spread from
primary infection elsewhere

28/10/2009

Signs & Symptoms


Symptoms
Dyspnea
Pleurisy
Cough
Discolored sputum
Signs
Cyanosis
Tachycardia
Tachypnea
Dull percussion
Crepitus
Bronchial breath sounds
Pleural rub
Sweating, cold clammy skin
Non-respiratory features
Confusion, fatigue
Diarrhea, N&V.
28/10/2009

Clinical Manifestations
CAP symptoms
Sudden onset of fever
Chills
Cough productive of purulent

sputum
Pleuritic chest pain

28/10/2009

Pathophysiology:
Pneumococcal Pneumonia
Congestion from outpouring of
fluid into alveoli
Microorganisms multiply and

spread infection, interfering with


lung function

28/10/2009

10

Pathophysiology:
Pneumococcal Pneumonia
Red hepatization
Massive dilation of capillaries
Alveoli fill with organisms,

neutrophils, RBCs, and fibrin


Causes lungs to appear red and

granular, similar to liver

28/10/2009

11

Complications
Pleurisy (pain with breathing)
Pleural effusion
Usually is sterile and reabsorbed in 1-2

weeks or requires thoracentesis

Atelectasis
Usually clears with cough and deep

breathing
28/10/2009

12

Complications
Delayed resolution
Persistent infection seen on x-ray as

residual consolidation

Lung abscess (pus-containing lesions)


Empyema (purulent exudate in pleural
cavity)
Requires antibiotics and drainage of

exudate

28/10/2009

13

Complications
Pericarditis
From spread of microorganism

Arthritis
Systemic spread of organism
Exudate can be aspirated

Meningitis
Patient who is disoriented, confused, or

somnolent should have lumbar puncture


to evaluate meningitis

28/10/2009

14

Complications
Endocarditis
Microorganisms attack endocardium and

heart valves
Manifestations similar to bacterial
endocarditis

28/10/2009

15

Diagnostic Tests
History
Physical exam
Chest x-ray
Gram stain of sputum
Sputum culture and sensitivity
Pulse oximetry or ABGs
CBC, differential, chems
Blood cultures
28/10/2009

16

Collaborative Care
Antibiotic therapy
Oxygen for hypoxemia
Analgesics for chest pain
Antipyretics
Influenza drugs
Influenza vaccine
Fluid intake at least 3 L per day
Caloric intake at least 1500 per day
28/10/2009

17

Collaborative Care
Pneumococcal vaccine
Indicated for those at risk
Chronic illness such as heart and lung

disease, diabetes mellitus


Recovering from severe illness
65 or older
In long-term care facility
28/10/2009

18

Nursing Assessment
History of Predisposing/Risk Factors
Lung cancer
COPD
Diabetes mellitus
Debilitating disease
Malnutrition

28/10/2009

19

Nursing Assessment
History of Predisposing/Risk Factors
AIDS
Use of antibiotics, corticosteroids,

chemotherapy, immunosuppressants
Recent abdominal or thoracic
surgery
Smoking, alcoholism, respiratory
infections
Prolonged bed rest
28/10/2009

20

Nursing Assessment
Clinical Manifestations
Dyspnea
Nasal congestion
Pain with breathing
Sore throat
Muscle aches
Fever
28/10/2009

21

Nursing Assessment
Clinical Manifestations
Restlessness or lethargy
Splinting affected area
Tachypnea
Asymmetric chest movements
Use of accessory muscles
Crackles
Green or yellow sputum
28/10/2009

22

Nursing Assessment
Clinical Manifestations
Tachycardia
Changes in mental status
Leukocytosis
Abnormal ABGs
Pleural effusion
Pneumothorax on CXR
28/10/2009

23

Nursing Diagnoses
Ineffective breathing pattern
Ineffective airway clearance
Acute pain
Imbalanced nutrition: less than body
requirements
Activity intolerance

28/10/2009

24

Planning
Goals: Patient will have
Clear breath sounds
Normal breathing patterns
No signs of hypoxia
Normal chest x-ray
No complications related to pneumonia

28/10/2009

25

Nursing Implementation
Teach nutrition, hygiene, rest, regular
exercise to maintain natural resistance
Prompt treatment of URIs

28/10/2009

26

Nursing Implementation
Encourage those at risk to obtain
influenza and pneumococcal
vaccinations
Reposition patient q2h
Assist patients at risk for aspiration
with eating, drinking, and taking meds

28/10/2009

27

Nursing Implementation
Assist immobile patients with turning
and deep breathing
Strict asepsis
Emphasize need to take course of
medication(s)
Teach drug-drug interactions

28/10/2009

28

Evaluation
Dyspnea not present
SpO2 > 95
Free of adventitious breath sounds
Clears sputum from airway

28/10/2009

29

Evaluation
Reports pain controlled
Verbalizes causal factors
Adequate fluid and caloric intake
Performs ADLs

28/10/2009

30

Tuberculosis
Famous people who have had TB
Fredric Chopin*
Eleanor Roosevelt*
Nelson Mandela
Ringo Starr
Tom Jones
Tina Turner
*Died of TB
28/10/2009

31

What is tuberculosis (TB)?


Disease caused by bacteria called
Mycobacterium tuberculosis
Chronic bacterial infection
Was once the leading cause of death in US
The number of cases declined in the 1940s
when drugs were developed to treat TB
TB is still a problem worldwide
8 million people develop TB yearly
3 million die

28/10/2009

32

Tuberculosis
5-10% become
active
Only contagious
when active
Primarily affect
lungs but
Kidneys
Liver
Brain
Bone
28/10/2009

33

How is TB spread?
Through the air from person to
person by coughing
Usually attacks lungs
Two stages
Latent TB
asymptomatic and not contagious
can take medication to prevent development of
disease

Active TB Disease
May

spread to others
May have abnormal chest x-ray
Usually have positive skin test
28/10/2009

34

Symptoms of TB
Chills
Fever
Weakness or fatigue
Sweating while sleeping, Night sweats
Cough that lasts longer than 2 weeks
Pain in chest
Coughing up blood or sputum

28/10/2009

35

Risk Factors
Close contact with someone who is infected
with TB
Traveling to a country where TB is common
Foreign-born individuals and minorities
have a higher incidence of developing TB
2002: 50% of US cases were in foreignborn individuals.
2002: 80% of all US TB cases were in
ethnic and racial minorities.
28/10/2009

36

Risk Factors
Immunocompromise
Substance abuse
Indigent (POVERTY)
Living in overcrowded, substandard housing
Health care workers performing high risk
activities

28/10/2009

37

Multi-drug resistant TB (MDR TB)


Bacteria become resistant to antibiotics
Arose from improper use of antibiotics in the
treatment of TB
Treatment of one case can cost up to $1.3 million
45 states and Washington, DC have confirmed cases
of MDR TB
Treatment is difficult and costly
Can develop from not taking proper course of
antibiotics for TB
MDR TB can be spread by an infected person

28/10/2009

38

How to protect yourself


BCG vaccine for TB is given in many countries
Not recommended for healthcare workers
unless a high percentage of patients are infected
with MDR TB
PPD test if exposure is suspected
USE proper PPE when in contact with patients
who may have TB
28/10/2009

39

PPD Skin Test Procedure


Intradermal administration of PPD
L forearm
Must be read between 48 and 72 hours
To accurately read
Visual inspection for erythema
Tactile inspection to monitor size of induration
10 mm or > area of induration
Consider positive
28/10/2009

and must be referred


40

Tuberculosis
Diagnostic exams
PPD
Mantoux skin test
> 10mm in diameter
induration
Indicates:
Latent TB
Read
48-72 after
Intradermal: 15-degrees
Do not rub

28/10/2009

41

Confirmation of Disease
Positive reaction does not
necessarily mean active disease.
May indicate exposure to TB
Diagnosis confirmed by:
Positive smear for AFB and
Sputum culture of
Mycobacterium tuberculosis
28/10/2009

42

Interventions
Combination drug
therapy
Isoniazid
Rifampicin
Pyrazinamide
Ethambutol or
streptomycin

Education
Must follow
exact drug
regimen
Proper
nutrition
Reverse weight

loss and lethargy

About disease
28/10/2009

43

Tuberculosis Treatment
INH
Isonicotinyl Hydrazine
Isoniazid
Toxic to the liver
Rifampicin
Turns urine red
Streptomycin
Causes 8th cranial nerve
damage
Acoustic nerve
28/10/2009

44

CLASSIFICATION
Class 0no exposure
Class 1exposure, no infection
Class 2latent infection; no disease (positive
PPD but no evidence of active TB
Class 3disease; clinically active
Class 4disease; not clinically active
Class 5suspected disease; diagnosis
pending
28/10/2009

45

MEDICAL MANAGEMENT
Treated with chemotherapeutic agents for 6-12
months
Resistance increasing. May be primary, secondary,
or multidrug resistant.
Primaryresistance to one of first line drugs in
those who have not had prior treatment
Secondaryresistance to one or more anti-TB
drugs in patients undergoing tx
Multidrug resistanceresistance to two agents,
INH and Rifampicin.
28/10/2009

46

Tuberculosis
Complications
Pleurisy
Pericarditis
Meningitis
Bone infections
Malnutrition
Drug-toxicity
28/10/2009

47

Tuberculosis
Nursing Dx
Impaired gas exchange
Ineffective airway clearance
Anxiety
Knowledge deficit
Alt. nutrition

28/10/2009

48

Tuberculosis
Preventative measures
Clean well ventilated living areas
Resp. isolation
Vaccine?
BCG
Does not prevent TB
Causes a + PPD
If exposed take
INH
28/10/2009

49

Tuberculosis Summary
Chronic bacterial infection
spread through the air
Fever, chills, sweating while sleeping,
persistent cough, coughing up blood or
sputum
Multi-drug-resistant tuberculosis MDR
TB
Use proper PPE and get PPD test if
exposed
28/10/2009

50

You might also like